Search Tag: cTRL Therapeutics

2023 12 Dec

cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes (cTRLs) in the blood to broaden the power and reach of solid tumor cell therapy announced the appointment of Ruben Rodriguez, Ph.D., as Head of Research. In this role, Dr. Rodriguez will lead research and early development efforts, helping guide strategy and...Read more